Literature DB >> 1415203

Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.

C A DeSoi1, D F Sahm, J G Umans.   

Abstract

Vancomycin clearance was measured in five patients during dialysis with cuprophane (CU), polysulfone (PS), cellulose triacetate (CT), and polyacrylonitrile (PAN) dialyzers. Vancomycin was significantly cleared during routine high-flux (HF) hemodialysis (HD) with the latter three membranes, but not by CU. Postdialytic rebound of serum vancomycin concentrations was noted following HF dialysis, necessitating use of a two-compartment pharmacokinetic model. Measurement of serum vancomycin concentration immediately postdialysis significantly overestimates intradialytic removal, possibly resulting in inappropriate dose adjustment. Vancomycin infusion during HF HD results in significant drug removal during its administration to the patient, complicating the calculation of an adequate dose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415203     DOI: 10.1016/s0272-6386(12)70298-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

Review 1.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 2.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 3.  Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.

Authors:  Michael A Veltri; Alicia M Neu; Barbara A Fivush; Rulan S Parekh; Susan L Furth
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Determination of vancomycin and gentamicin clearance in an in vitro, closed loop dialysis system.

Authors:  Soo Min Jang; Katie E Cardone; Thomas D Nolin; Darius L Mason; Darren W Grabe
Journal:  BMC Nephrol       Date:  2014-12-20       Impact factor: 2.388

5.  Treatment of paediatric vancomycin intoxication: a case report and review of the literature.

Authors:  Mathieu Lemaire; Bairbre Connolly; Elizabeth Harvey; Christoph Licht
Journal:  NDT Plus       Date:  2010-03-17

Review 6.  Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application.

Authors:  Wei-Chih Kan; Yi-Chih Chen; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

7.  Construction of a prediction model for drug removal rate in hemodialysis based on chemical structures.

Authors:  Kousuke Nishikiori; Kentaro Tanaka; Yoshihiro Uesawa
Journal:  Mol Divers       Date:  2022-01-01       Impact factor: 3.364

Review 8.  Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review.

Authors:  Anri Sawada; Kunio Kawanishi; Shohei Morikawa; Toshihiro Nakano; Mio Kodama; Mitihiro Mitobe; Sekiko Taneda; Junki Koike; Mamiko Ohara; Yoji Nagashima; Kosaku Nitta; Takahiro Mochizuki
Journal:  BMC Nephrol       Date:  2018-03-27       Impact factor: 2.388

9.  In vivo evaluation of drug dialyzability in a rat model of hemodialysis.

Authors:  Masaki Fukunaga; Daisuke Kadowaki; Mika Mori; Satomi Hagiwara; Yuki Narita; Junji Saruwatari; Ryota Tanaka; Hiroshi Watanabe; Keishi Yamasaki; Kazuaki Taguchi; Hiroki Ito; Toru Maruyama; Masaki Otagiri; Sumio Hirata
Journal:  PLoS One       Date:  2020-06-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.